In situ Metabolomics of Metabolic Reprogramming Involved in a Mouse Model of Type 2 Diabetic Kidney Disease
The in situ metabolic profiling of the kidney is crucial to investigate the complex metabolic reprogramming underlying diabetic kidney disease (DKD) and to allow exploration of potential metabolic targets to improve kidney function. However, as the kidney is a highly heterogeneous organ, traditional...
Guardado en:
Autores principales: | Bai Linnan, Wang Yanzhe, Zhang Ling, Liu Yuyuan, Chen Sijia, Xie Xinmiao, Li Fengqin, Wang Xiaoxia |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/378c65e7afa5459098cde860ba9ff152 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Spatial-resolved metabolomics reveals tissue-specific metabolic reprogramming in diabetic nephropathy by using mass spectrometry imaging
por: Zhonghua Wang, et al.
Publicado: (2021) -
Recent Metabolomics Analysis in Tumor Metabolism Reprogramming
por: Jingjing Han, et al.
Publicado: (2021) -
Unravelling the Anticancer Mechanisms of Traditional Herbal Medicines with Metabolomics
por: Omolola R. Oyenihi, et al.
Publicado: (2021) -
Metabolomic Characterization of Cerebrospinal Fluid from Intracranial Bacterial Infection Pediatric Patients: A Pilot Study
por: Yiwen Wang, et al.
Publicado: (2021) -
Metabolic Reprogramming and Renal Fibrosis
por: Xiaoyu Zhu, et al.
Publicado: (2021)